ClinConnect ClinConnect Logo
Search / Trial NCT06036498

Evaluation of Cerebral Blood Flow and Cerebral Oxygenation With Transcranial Doppler and NIRS in Laparoscopic Cholecystectomy Cases

Launched by ULUDAG UNIVERSITY · Sep 6, 2023

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Near Infra Red Spectrophotometry Cerebral Oxygenisation Transcranial Doppler Ultrasonography (Tcd) Laparoscopic Surgery

ClinConnect Summary

This clinical trial is studying how certain changes in blood flow and oxygen levels in the brain occur during a specific type of surgery called laparoscopic cholecystectomy, which is commonly performed to remove the gallbladder. The researchers want to understand how a technique called pneumoperitoneum, which involves inflating the abdomen with gas to allow better access to the organs, affects blood flow in the brain. They will use two different methods, Near-Infrared Spectroscopy (NIRS) and Transcranial Doppler (TCD) ultrasonography, to measure these changes and see if one method is more effective than the other.

To participate in this trial, you need to be between 18 and 65 years old and scheduled for this type of surgery. The study is looking for patients in good health (classified as ASA 1-3), meaning they have no serious health issues. However, individuals with certain medical conditions, such as severe heart or vascular diseases, or those who have had a stroke, cannot participate. If you join the study, you can expect to have your brain's blood flow and oxygen levels monitored during your surgery to help researchers gather important information that may improve patient care in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with American Society of Anesthesiology (ASA) 1-3 classification,
  • Both male and female patients between the ages of 18 to 65,
  • Patients scheduled for elective laparoscopic cholecystectomy.
  • Exclusion Criteria:
  • American Society of Anesthesiology (ASA) 4 and above patient groups,
  • Patients aged under 18 and over 65,
  • Patients with a history of known previous cerebrovascular accident (CVA),
  • Patients with follow-up due to Cerebrovascular Ischemic Brain Attack Syndrome (CIBAS),
  • Patients diagnosed with Carotid Stenosis,
  • Patients diagnosed with peripheral and central vascular diseases,
  • Patients with general debilitation and extreme senility,
  • Cases that require conversion to laparotomy during the intraoperative period.

About Uludag University

Uludağ University is a leading academic institution located in Bursa, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Uludağ University leverages its extensive expertise and resources to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university's collaborative approach fosters partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring rigorous adherence to ethical standards and regulatory guidelines. Through its clinical trials, Uludağ University aims to contribute significantly to the scientific community and enhance the understanding of various medical conditions and treatments.

Locations

Bursa, Nilufer, Turkey

Patients applied

0 patients applied

Trial Officials

Kadir Bugra Basaran

Study Chair

Uludag University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported